Search results
Sarepta’ stock soars 38% after FDA expands approval for DMD drug
Market Watch· 56 minutes agoDuchenne muscular dystrophy is a genetic disease that primarily affects boys and causes muscle...
FDA expands approval of first gene therapy for rare form of muscular dystrophy
CNN.com· 14 hours agoThe US Food and Drug Administration has given the green light for the first gene therapy that treats...
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
Investor's Business Daily· 2 hours agoSarepta stock rocketed early Friday after the Food and Drug Administration approved its Duchenne ...
Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug
Bloomberg via Yahoo Finance· 51 minutes ago(Bloomberg) -- Sarepta Therapeutics Inc.’s gene therapy received expanded US approval to include...
Wareham girl with muscular dystrophy treks along Jurassic coast
BBC News· 7 hours agoA 10-year-old girl with muscular dystrophy is travelling 100 miles over two weeks to raise money for charity. Carmela, from Wareham, began walking, and ...
Limb girdle muscular dystrophy: Symptoms, causes, and more
Medical News Today· 2 days agoLimb-girdle muscular dystrophy (LGMD) is a group of health conditions that can cause weakness and...
These Stocks Are Moving the Most Today: Microsoft, Nvidia, Trump Media, Sarepta, Gilead, CarMax, and...
Barrons.com· 1 hour agoMicrosoft again tops Nvidia as the world’s most valuable company, Trump Media shares post a modest...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 24 minutes agoThe decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable public company. Sarepta Therapeutics — The biopharma stock soared 37% after the U.S. Food and ...
Global Nonprofit CureDuchenne to Host Informational Webinars Following FDA Label Expansion of...
FOX 23 News Albany· 12 hours agoCureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, will host webinars in English and Spanish for ...
Sarepta Stock Surges on Expanded Approval for Elevidys. What Wall Street Thinks.
Barrons.com· 60 minutes agoThe biopharmaceutical company says the drug was approved for ambulatory and non-ambulatory people,...